skip to Main Content

Vaccines / Preventive Services

Adult immunization rates are falling short of national targets. Learn how global, federal, and state policies affect vaccination uptake. Leverage our findings to guide your strategies. Rely on our expertise commercializing novel and therapeutic vaccines.

Richard Hughes

Webinar: 2019 Avalere Webinar Series: A Conversation on Vaccine Innovations

With a robust vaccines pipeline and opportunities to improve adult vaccine access, vaccines are currently a hot topic. In our 30-minute Conversations series, Avalere’s experts will break down the issues surrounding vaccines, what those issues mean, and their impact on various healthcare stakeholders. They will also provide insights on what to expect from the Advisory Committee on Immunization Practice’s meeting scheduled for June 26–27.

Neil Rosacker

Administration Seeks Input on Federal STD Prevention and Treatment Initiative

On May 3, the Office of HIV/AIDS and Infectious Disease Policy, in partnership with other Department of Health and Human Services agencies, released a request for information (RFI) from stakeholders on strategies for the development of a Sexually Transmitted Diseases (STDs) Federal Action Plan, an initiative designed to address the domestic STD public health epidemic.

Richard Hughes

Vaccine Exemptions and the Federal Government’s Role

With the number of measles cases rising across the country, FDA Commissioner Scott Gottlieb raised the prospect of federal intervention over exemptions to state-level immunization school-entry requirements. While not specifying what role the federal government would play, Gottlieb stated, “You could mandate certain rules about what is and isn’t permissible when it comes to allowing people to have exemptions.”

Richard Hughes

Lack of Clarity on Preventive Services Recommendations May Create Access Barriers

Ambiguous recommendations for preventive services are causing confusion among plans and providers on the clinically recommended preventive services that should be covered without cost sharing. A recent USPSTF recommendation on HIV prevention offers an opportunity to urge a recommending body to provide further clarity in its recommendation. Comments are due December 26.

Back To Top